Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Pain & musculoskeletal carePRM 0023
Dosage formTablets
Oral

(6S) 5-Methyltetrahydrofolic Acid, Glucosamine Salt (MD)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Haematinic & nutritional supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 1393
Dosage formTopical gel
Topical

Aceclofenac 1.50% w/v, Capsaicin 0.01% w/v, Linseed Oil 3% w/v, Menthol 5% w/v, Methyl Salicylate 10% w/v

Route
Topical
Formulation type
Topical semi-solid gel
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Topical
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0032
Dosage formTablets
Oral

Aceclofenac 100 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Class II
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0033
Dosage formTablets
Oral

Aceclofenac 100 mg (SR)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Class II
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0034
Dosage formTablets
Oral

Aceclofenac 100 mg, Bromelain 90 mg, Rutoside Trihydrate 100 mg, Trypsin 48 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0035
Dosage formTablets
Oral

Aceclofenac 100 mg, Caffeine 25 mg, Cetirizine 10 mg, Paracetamol 325 mg, Phenylephrine 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0036
Dosage formTablets
Oral

Aceclofenac 100 mg, Chlorzoxazone 250 mg, Paracetamol 325 mg Film Coated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0037
Dosage formTablets
Oral

Aceclofenac 100 mg, Chlorzoxazone 250 mg, Paracetamol 325 mg Uncoated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0038
Dosage formTablets
Oral

Aceclofenac 100 mg, Diacerein 50 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Class II
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0039
Dosage formTablets
Oral

Aceclofenac 100 mg, Drotaverine 80 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Antispasmodic
Manufacturing stream
Non-beta-lactam
BCS class
Class II
CDSCO categoryFDC
Documented match

Listed in CDSCO FDC approval records

CDSCO filing reference · page 540
Pain & musculoskeletal carePRM 2594
Dosage formTablets
Oral

Aceclofenac 100 mg, Etoricoxib 60 mg, Thiocolchicoside 4 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic + Skeletal muscle relaxant
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 2148
Dosage formHard-gelatin capsules
Oral

Aceclofenac 100 mg, Misoprostol 100 mcg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gastroprotective agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 468
Pain & musculoskeletal carePRM 0040
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg Film Coated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 463
Pain & musculoskeletal carePRM 0041
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg Uncoated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 463
Pain & musculoskeletal carePRM 0042
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg, Serratiopeptidase 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0043
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg, Serratiopeptidase 15 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0044
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg, Thiocolchicoside 4 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0045
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg, Thiocolchicoside 8 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0046
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg, Tolperisone 150 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0048
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg, Trypsin Chymotrypsin 100000 AU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0047
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg, Trypsin Chymotrypsin 150000 AU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0049
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 325 mg, Trypsin Chymotrypsin 50000 AU

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 2595
Dosage formTablets
Oral

Aceclofenac 100 mg, Paracetamol 500 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Non-opioid analgesic / antipyretic + NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Pain & musculoskeletal carePRM 0050
Dosage formTablets
Oral

Aceclofenac 100 mg, Serratiopeptidase 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product